Evidence map›Paper›PMID 34490824›Full record

ArticleIntegrative cancer therapies

Thymoquinone and Costunolide Induce Apoptosis of Both Proliferative and Doxorubicin-Induced-Senescent Colon and Breast Cancer Cells.

Ali H El-Far, Kavitha Godugu, Ahmed E Noreldin, Amna A Saddiq, Omar A Almaghrabi, Soad K Al Jaouni, Shaker A Mousa

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Integrative cancer therapies. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Effect ofCurrent issues in molecular biology · 2023
    Review
  11. Article
  12. Rutin and Hesperidin Revoke the Hepatotoxicity Induced by Paclitaxel in Male Wistar RatsEvidence-based complementary and alternative medicine : eCAM · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Evidence-based complementary and alternative medicine : eCAM · 2022
    Article
  17. Grain-Sized Moxibustion Heightens the AntiTumor Effect of Cyclophosphamide in Hepa1-6 Bearing Mice.Evidence-based complementary and alternative medicine : eCAM · 2022
    Article
  18. Article
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Ali H El-FarDamanhour University, Damanhour, Al-Beheira, Egypt.ORCID 0000-0001-9721-4360
Kavitha GoduguAlbany College of Pharmacy and Health Sciences, Rensselaer, NY, USA.
Ahmed E NoreldinDamanhour University, Damanhour, Al-Beheira, Egypt.
Amna A SaddiqUniversity of Jeddah, Jeddah, Makkah, Saudi Arabia.
Omar A AlmaghrabiUniversity of Jeddah, Jeddah, Makkah, Saudi Arabia.
Soad K Al JaouniKing Abdulaziz University, Jeddah, Saudi Arabia.
Shaker A MousaAlbany College of Pharmacy and Health Sciences, Rensselaer, NY, USA.
Albany College of Pharmacy and Health Sciences · USDamanhour University · EGUniversity of Jeddah · SAKing Abdulaziz University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Doxorubicin (Dox) induces senescence in numerous cancer cell types, but these senescent cancer cells relapse again if they are not eliminated. On this principle, we investigated the apoptotic effect of thymoquinone (TQ), the active ingredient of

Indexed as

ApoptosisNeoplasm Recurrence, LocalBenzoquinonesColonDoxorubicinHumansLactonesSesquiterpenesBenzoquinonescostunolideDoxorubicinLactonesSesquiterpenesthymoquinoneapoptosiscostunolidesenescencethymoquinone

Identifiers

PMID34490824
PMCPMC8427913
OpenAlexW3198316134

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.